Austin J R, Byers R M, Brown W D, Wolf P
Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, USA.
Head Neck. 1996 Mar-Apr;18(2):107-17. doi: 10.1002/(SICI)1097-0347(199603/04)18:2<107::AID-HED1>3.0.CO;2-5.
This study was performed to determine the effect of biopsy type on survival rates and on local, regional, and distant metastasis in patients with head and neck cutaneous melanoma.
A case series of 159 patients with melanoma of the head and neck referred to a tertiary-care center between 1983 and 1991, with a median follow-up of 38 months, was reviewed. Information analyzed included patient's age, sex, type of treatment, mode of biopsy, presence of residual melanoma in reexcision, location of lesion, presence of ulceration, Clark's level, Breslow thickness, and histologic type of the melanoma.
Excisional biopsy was performed in 79 patients, incisional biopsy in 48, and other procedures (shave, needle biopsy, cauterization, or cryotherapy) in 32. There were no significant pretreatment differences among the three groups in sex, thickness, histologic type, presence of nodal disease, or type of treatment. Pretreatment location of lesion was significantly different (p = .03) between the excisional and other biopsy types. Association between type of biopsy and survival rate was significant (p<.001):31.3% of patients in the incisional biopsy group died of disease, as did 25% of the other biopsy group, versus 8.9% of the excisional biopsy group; 31.3% of patients in the incisional biopsy group developed distant metastases, as did 28.1% of the other biopsy type, versus 10.1% of those in the excisional biopsy group (p = .01). There was no significant difference in local p = .37) or regional (p = 1.00) recurrence among the three biopsy groups. Multivariate analysis showed presence of tumor in the re-excision specimen, biopsy type, and nodal disease to be independent prognostic factors.
Our study suggests that the type of biopsy of cutaneous melanoma of the head and neck may influence the clinical outcome.
本研究旨在确定活检类型对头颈部皮肤黑色素瘤患者生存率以及局部、区域和远处转移的影响。
回顾了1983年至1991年间转诊至三级医疗中心的159例头颈部黑色素瘤患者的病例系列,中位随访时间为38个月。分析的信息包括患者的年龄、性别、治疗类型、活检方式、再次切除时残留黑色素瘤的情况、病变位置、溃疡情况、克拉克分级、布雷斯洛厚度以及黑色素瘤的组织学类型。
79例患者进行了切除活检,48例进行了切开活检,32例进行了其他操作(刮除、针吸活检、烧灼或冷冻治疗)。三组在性别、厚度、组织学类型、淋巴结疾病情况或治疗类型方面,术前无显著差异。切除活检和其他活检类型之间病变的术前位置存在显著差异(p = 0.03)。活检类型与生存率之间的关联具有显著性(p<0.001):切开活检组31.3%的患者死于疾病,其他活检组为25%,而切除活检组为8.9%;切开活检组31.3%的患者发生远处转移,其他活检类型组为28.1%,而切除活检组为10.1%(p = 0.01)。三组在局部复发(p = 0.37)或区域复发(p = 1.00)方面无显著差异。多变量分析显示,再次切除标本中肿瘤的存在、活检类型和淋巴结疾病是独立的预后因素。
我们的研究表明,头颈部皮肤黑色素瘤的活检类型可能会影响临床结果。